NeurosciencebioRxivPreprint
Intranasal CRISPR- lipid nanoparticles targeting MAPK9 reduce neuroinflammation after traumatic brain injury
Göknur Kara, Yaqoob Ali, Jessica López Espinosa…·Sonia Villapol
This paper develops an intranasal CRISPR-based therapy targeting MAPK9 in microglia to reduce neuroinflammation after traumatic brain injury, showing reduced inflammation and no toxicity.
DOI 10.64898/2026.04.25.720847